Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSUVASTATIN for Type iia hyperlipidaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 547 adverse event reports in the FDA FAERS database where ROSUVASTATIN was used for Type iia hyperlipidaemia.

Most Reported Side Effects for ROSUVASTATIN

Side Effect Reports % Deaths Hosp.
Myalgia 3,958 10.9% 29 610
Dyspnoea 2,832 7.8% 47 999
Pain 2,758 7.6% 20 868
Drug ineffective 2,347 6.5% 41 706
Fatigue 2,208 6.1% 28 661
Rhabdomyolysis 2,173 6.0% 134 1,555
Arthralgia 1,879 5.2% 1 226
Asthma 1,843 5.1% 31 511
Muscle spasms 1,843 5.1% 3 242
Pain in extremity 1,686 4.6% 5 248
Drug hypersensitivity 1,669 4.6% 19 214
Cough 1,656 4.6% 7 522
Headache 1,651 4.5% 22 577
Off label use 1,594 4.4% 29 554
Acute kidney injury 1,568 4.3% 100 1,193

Other Indications for ROSUVASTATIN

Product used for unknown indication (11,569) Blood cholesterol increased (3,321) Hypercholesterolaemia (2,690) Dyslipidaemia (2,032) Hyperlipidaemia (1,591) Blood cholesterol abnormal (1,590) Blood cholesterol (975) Coronary artery disease (600) Cerebrovascular accident (515) Ill-defined disorder (361)

Other Drugs Used for Type iia hyperlipidaemia

EVOLOCUMAB (5,556) LOMITAPIDE (3,314) ALIROCUMAB (1,913) ATORVASTATIN (637) EZETIMIBE (562) INCLISIRAN (313) SIMVASTATIN (294) PRAVASTATIN (152) JUXTAPID (145) MIPOMERSEN (138)

Related Pages

ROSUVASTATIN Full Profile All Type iia hyperlipidaemia Drugs ROSUVASTATIN Demographics ROSUVASTATIN Timeline